Form 4: BioLife Solutions Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Todd Berard, Chief Marketing Officer of BioLife Solutions, sold 73 shares of common stock on May 17, 2024, to satisfy tax withholding obligations related to vesting restricted stock.
Summary
- On May 17, 2024, Todd Berard, the Chief Marketing Officer of BioLife Solutions Inc., sold 73 shares of the company's common stock.
- The sale was executed at a price of $22.18 per share.
- This transaction was conducted under a pre-arranged Rule 10b5-1(c) trading plan adopted on February 8, 2021.
- The purpose of the sale was to cover tax withholding obligations associated with the vesting of restricted stock.
- Following the transaction, Berard directly owns 119,239 shares of BioLife Solutions Inc.
Sentiment
Score: 6
Explanation: The document describes a routine stock sale for tax purposes, which is neutral. The existence of a 10b5-1 plan suggests pre-planned transactions, reducing potential negative interpretations.
Industry Context
This is a routine transaction related to executive compensation and tax obligations. It doesn't necessarily reflect a change in the executive's confidence in the company's future prospects.
Stakeholder Impact
- The sale of a small number of shares by an executive is unlikely to have a significant impact on shareholders.
Key Dates
| Date | Description |
|---|---|
| 02/08/2021 | Date of adoption of Rule 10b5-1(c) trading plan |
| 05/17/2024 | Date of stock sale transaction |
| 05/21/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.